Skip to main content

News in Ankylosing Spondylitis

Rheumatology Consultant
January 28, 2020
Johan K. Wallman, MD, PhD, from Lund University, answers our questions about his research on the prevalence of gut symptoms meeting criteria for irritable bowel syndrome (IBS) among patients with axial spondyloarthritis compared with a control group.
Rheumatology Consultant
January 24, 2020
Authors of the MEASURE 3 study have shared their end‐of‐study 3‐year efficacy and safety results of secukinumab, 150 mg and 300 mg, among patients with active ankylosing spondylitis. Find out what the researchers determined.
Rheumatology Consultant
October 23, 2019
Jean Liew, MD, from the University of Washington, answers our questions about the relationship between cardiovascular risk and nonsteroidal anti-inflammatory drug use in the management of ankylosing spondylitis.
Rheumatology Consultant
August 23, 2019
The ACR, SAA, and SPARTAN released an updated guideline for the management of AS and axial SpA that provides an overview of new treatment options and the use of imaging.
Rheumatology Consultant
April 18, 2019

Researchers evaluated the risk of venous thromboembolism and other venous events among more than 7000 individuals with ankylosing spondylitis.

Rheumatology Consultant
December 19, 2018
Since ankylosing spondylitis can impact individuals who are of working age, researchers sought to determine the disease’s impact on overall work stability.
Rheumatology Consultant
December 14, 2018
Take our poll on the rheumatologist’s role in determining whether a patient with ankylosing spondylitis is emotionally and psychologically healthy.
Rheumatology Consultant
December 03, 2018
Researchers analyzed whether C-reactive protein level can be used to predict how a patient with ankylosing spondylitis will react to tumor necrosis factor-α blocker treatment.
Rheumatology Consultant
November 28, 2018
Researchers evaluated more than 90 patients with AS to determine the effect of golimumab on acute anterior uveitis occurrence.
Rheumatology Consultant
November 20, 2018
To allow heath care providers to make the most informed treatment decisions for ankylosing spondylitis, researchers evaluated the efficacy and safety of long-term use of secukinumab.
Back to Top